Comparison of Clinical Manifestation and Mortality-Related Risk Factors Between Elderly and Middle-Aged COVID-19 Patients

Q3 Medicine Acta medica Iranica Pub Date : 2024-04-05 DOI:10.18502/acta.v61i9.15282
Majid Akrami, Hadiseh Hosamirudsari, Neda Faraji, Masoomeh Nataj Majd
{"title":"Comparison of Clinical Manifestation and Mortality-Related Risk Factors Between Elderly and Middle-Aged COVID-19 Patients","authors":"Majid Akrami, Hadiseh Hosamirudsari, Neda Faraji, Masoomeh Nataj Majd","doi":"10.18502/acta.v61i9.15282","DOIUrl":null,"url":null,"abstract":"Given that the risk factors associated with mortality and morbidity of Coronavirus Disease (COVID-19) vary among age groups, this study aimed to describe the differences in clinical characteristics and mortality-related risk factors between elderly and middle-aged COVID-19 patients. A total of 1061 patients were included in this retrospective cohort study. Patients’ radiology reports and laboratory data were extracted from the available data on the Hospital Information System (HIS), and clinical findings were added in special forms. We followed up cases until death or discharge to evaluate patients’ outcomes. Chronic obstructive pulmonary disease (COPD) (95% CI, HR 2.73 (0.97-6.62)), need for antibiotics (95% CI, HR 2.26 (1.20-4.26)), and diabetes (95% CI, HR 1.77 (0.97-3.24)) were associated with a higher risk of mortality among middle-aged COVID-19 patients; while, age (95% CI, HR 1.04 (1.01-1.06)) was associated with increased mortality rate in elderly patients. We found that the need for antibiotics was associated with a worse outcome of COVID-19. Additionally, we described the differences between elderly and middle-aged COVID-19 patients regarding their comorbidities, laboratory findings, and clinical manifestation.","PeriodicalId":6946,"journal":{"name":"Acta medica Iranica","volume":"36 5","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-04-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Acta medica Iranica","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.18502/acta.v61i9.15282","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Given that the risk factors associated with mortality and morbidity of Coronavirus Disease (COVID-19) vary among age groups, this study aimed to describe the differences in clinical characteristics and mortality-related risk factors between elderly and middle-aged COVID-19 patients. A total of 1061 patients were included in this retrospective cohort study. Patients’ radiology reports and laboratory data were extracted from the available data on the Hospital Information System (HIS), and clinical findings were added in special forms. We followed up cases until death or discharge to evaluate patients’ outcomes. Chronic obstructive pulmonary disease (COPD) (95% CI, HR 2.73 (0.97-6.62)), need for antibiotics (95% CI, HR 2.26 (1.20-4.26)), and diabetes (95% CI, HR 1.77 (0.97-3.24)) were associated with a higher risk of mortality among middle-aged COVID-19 patients; while, age (95% CI, HR 1.04 (1.01-1.06)) was associated with increased mortality rate in elderly patients. We found that the need for antibiotics was associated with a worse outcome of COVID-19. Additionally, we described the differences between elderly and middle-aged COVID-19 patients regarding their comorbidities, laboratory findings, and clinical manifestation.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
老年和中年 COVID-19 患者的临床表现和死亡相关风险因素比较
鉴于与冠状病毒病(COVID-19)死亡率和发病率相关的风险因素因年龄而异,本研究旨在描述老年和中年COVID-19患者在临床特征和死亡率相关风险因素方面的差异。这项回顾性队列研究共纳入了 1061 名患者。我们从医院信息系统(HIS)的可用数据中提取了患者的放射学报告和实验室数据,并在特殊表格中添加了临床发现。我们对病例进行了随访,直到患者死亡或出院,以评估患者的预后。慢性阻塞性肺病(COPD)(95% CI,HR 2.73 (0.97-6.62))、需要使用抗生素(95% CI,HR 2.26 (1.20-4.26))和糖尿病(95% CI,HR 1.77 (0.97-3.24))与中年 COVID-19 患者较高的死亡风险相关;而年龄(95% CI,HR 1.04 (1.01-1.06))与老年患者死亡率的增加相关。我们发现,需要使用抗生素与 COVID-19 较差的预后有关。此外,我们还描述了老年和中年 COVID-19 患者在合并症、实验室检查结果和临床表现方面的差异。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Acta medica Iranica
Acta medica Iranica Medicine-Medicine (all)
CiteScore
0.70
自引率
0.00%
发文量
83
审稿时长
18 weeks
期刊介绍: ACTA MEDICA IRANICA (p. ISSN 0044-6025; e. ISSN: 1735-9694) is the official journal of the Faculty of Medicine, Tehran University of Medical Sciences. The journal is the oldest scientific medical journal of the country, which has been published from 1960 onward in English language. Although it had been published quarterly in the past, the journal has been published bimonthly (6 issues per year) from the year 2004. Acta Medica Iranica it is an international journal with multidisciplinary scope which publishes original research papers, review articles, case reports, and letters to the editor from all over the world. The journal has a wide scope and allows scientists, clinicians, and academic members to publish their original works in this field.
期刊最新文献
Effect of Gestational Hypertension on Neonatal Hemoglobin Level A Review on Novel Methods of Pharmacology Teaching Concerning Iranian Academic Context Transcatheter Closure of a Huge Congenital Coronary-Cameral Fistula With Amplatzer Occluder Erythrocyte Antioxidants and Hexokinase Activity Alterations in CCl4-Induced Cirrhotic Rats Through Naltrexone Treatment Upright Versus Recumbent Position in the Second Stage of Labor for Women With Epidural Analgesia: A Randomized Clinical Trial
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1